Premium
Letter: when to withhold anti‐TNF agents prior to abdominal surgery in patients with Crohn’s disease—the jury might still be out. Authors’ reply
Author(s) -
Lin YangSheng,
Lin WeiChen,
Chen MingJen,
Wang YuanHung,
Chen Chiehfeng
Publication year - 2019
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.15398
Subject(s) - medicine , crohn's disease , disease , jury , abdominal surgery , crohn disease , tumor necrosis factor alpha , surgery , general surgery , pathology , law , political science